Skip to main content
. 2021 Apr 19;11(2):20458940211007040. doi: 10.1177/20458940211007040

Table 4.

Multivariable logistic regression for 30-day ventilator use, vasopressor use, and renal replacement therapy.

Variables VentilatorOR (95% CI) p-value H  C VasopressorOR (95% CI) p-value H  C Renal RTOR (95% CI) p-value H  C
Left ventricular 0.88 0.70
systolic function
 Normal 1.00 1.00 1.00
 Mildly reduced 1.13 (0.47, 2.70) 0.79 1.29 (0.56, 2.98) 0.55 1.29 (0.51, 3.27) 0.59
 Moderately reduced 2.20 (0.57, 8.51) 0.25 3.87 (0.93, 16.05) 0.06 4.17 (1.12, 15.53) 0.03
 Severely reduced 0.78 (0.23, 2.68) 0.70 1.27 (0.38, 4.26) 0.70 3.44 (1.05, 11.27) 0.04
Left ventricular EDD 0.98 (0.60, 1.61) 0.95 1.06 (0.66, 1.70) 0.81 1.08 (0.65, 1.78) 0.77
Right ventricular systolic function 0.18 0.75 0.43 0.69 0.88 0.75
 Normal 1.00 1.00 1.00
 Mildly reduced 1.55 (0.71, 3.35) 0.27 2.26 (1.06, 4.85) 0.04 3.11 (1.43, 6.74) 0.004
 Moderate to severely reduced 3.49 (1.08, 11.29) 0.04 3.69 (1.19, 11.41) 0.02 7.71 (2.56, 23.22) <0.001
Right ventricular size (enlarged) 1.50 (0.79, 2.88) 0.22 1.80 (0.96, 3.37) 0.07 3.11 (1.58, 6.12) 0.001 0.38 0.73
Right ventricular S′ 1.07 (0.96, 1.19) 0.25 1.05 (0.95, 1.17) 0.33 0.89 (0.79, 1.01) 0.07
Pulmonary hypertension (present) 3.96 (1.33, 11.75) 0.01 0.29 0.83 4.88 (1.69, 14.09) 0.003 0.02 0.81 2.48 (0.85, 7.24) 0.10
LV diastolic function
 Normal 1.00 1.00 1.00
 Grade 1 dysfunction 1.12 (0.38, 3.30) 0.83 0.89 (0.32, 2.52) 0.83 1.02 (0.31, 3.30) 0.98
 Grade 2 dysfunction 0.67 (0.12, 3.66) 0.64 0.47 (0.09, 2.48) 0.47 1.58 (0.24, 10.34) 0.63
 Grade 3 dysfunction 0.51 (0.10, 2.53) 0.41 0.62 (0.13, 2.92) 0.54 2.14 (0.40, 11.48) 0.37
Mitral regurgitation
 None 1.00 1.00 1.00
 Mild 0.53 (0.24, 1.15) 0.11 0.68 (0.32, 1.42) 0.30 0.69 (0.29, 1.65) 0.40
 Moderate to severe 0.39 (0.13, 1.19) 0.10 0.67 (0.24, 1.87) 0.45 1.01 (0.32, 3.14) 0.99
Aortic regurgitation
 None 1.00 1.00 1.00
 Mild 0.70 (0.28, 1.76) 0.45 0.67 (0.28, 1.64) 0.38 0.70 (0.23, 2.09) 0.52
 Moderate to severe 0.41 (0.13, 1.27) 0.12 1.05 (0.36, 3.09) 0.93 0.69 (0.20, 2.37) 0.56
Tricuspid regurgitation 0.64 0.74
 None 1.00 1.00 1.00
 Mild 1.28 (0.64, 2.57) 0.49 1.64 (0.84, 3.21) 0.15 1.95 (0.90, 4.22) 0.09
 Moderate to severe 1.16 (0.52, 2.63) 0.72 1.66 (0.75, 3.68) 0.21 6.63 (2.58, 17.02) <0.001
Pulmonic regurgitation
 None 1.00 1.00 1.00
 Mild 0.49 (0.21, 1.13) 0.09 0.58 (0.26, 1.30) 0.19 1.67 (0.67, 4.15) 0.27
 Moderate to severe 0.68 (0.17, 2.69) 0.59 0.66 (0.18, 2.49) 0.54 2.98 (0.73, 12.16) 0.13
Left atrial volume index 1.01 (0.99, 1.03) 0.56 1.00 (0.98, 1.02) 0.95 1.01 (0.99, 1.03) 0.33
Pericardial effusion (present) 1.39 (0.52, 3.71) 0.52 1.84 (0.71, 4.81) 0.21 1.33 (0.48, 3.69) 0.58

Note: All multivariable analyses adjust for age, sex, coronary artery disease, hypertension, diabetes mellitus, and chronic obstructive pulmonary disease. Analyses classifying all missing data for pulmonary hypertension as absence of pulmonary hypertension showed significantly increased odds for those with pulmonary hypertension for ventilator (OR: 2.30, 95% CI: 1.17, 4.52, p = 0.02, H = 0.19, c = 0.75), vasopressor (OR: 2.58, 95% CI: 1.34, 4.97, p = 0.01, H = 0.99, c = 0.70), renal replacement therapy (OR: 3.10, 95% CI: 1.55, 6.20, p = 0.001). OR: odds ratio; CI: confidence interval; RT: replacement therapy; EDD: end diastolic dimension; H: Hosmer and Lemenshow goodness-of-fit test; C: C statistic.